Purchase Order HHSN272201501281P
- Not listed
- The Department of Health and Human Services' National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a firm fixed price delivery order to Illumina, Inc., a for-profit manufacturer of genomic sequencing instruments and reagents, for the purchase of TruSeq sequencing kits. The order, valued at $8,623.90, does not have a set-aside designation. Illumina has previously received prime federal contract awards from agencies like the National Institutes of Health,...
- This federal contract award from the National Institute of Allergy and Infectious Diseases (NIAID), a division of the National Institutes of Health (NIH), was issued to Illumina, Inc., a manufacturer of sequencing and array-based solutions for genetic and genomic analysis. The $24,385.03 firm fixed price purchase order does not have a set-aside designation. The award supports Illumina's provision of goods and services related to genomic sequencing and analysis, potentially for research and...
- This federal contract award was made by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Illumina, Inc., a manufacturer of genomic sequencing instruments and reagents. The $5,626.82 firm fixed price delivery order is for the purchase of Illumina's TruSeq SBS Kit v3 - HS - 50-Cycle, which supports high-throughput DNA sequencing. The award has no set-aside designation and appears to align with NIAID's mission to support...
- This is a firm fixed price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to Illumina, Inc., a manufacturer of sequencing and genomic analysis instruments and reagents. The $4,638.33 contract is for Illumina reagent kits to support the agency's research and diagnostic needs. Illumina has a history of providing sequencing systems, reagents, and bioinformatics products to federal agencies like the CDC,...
- This is a federal purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to Illumina, Inc. The $8,734 firm fixed-price contract is for the delivery of Illumina's sequencing systems, reagents, and related services to support genomic research and analysis. Illumina is a manufacturer of sequencing and array-based solutions for genetic and genomic analysis. The contract has no set-aside designation....
- This federal contract was awarded by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases to Illumina, Inc., a manufacturer of genetic sequencing systems and reagents. The $148,811.70 firm fixed price delivery order is for the provision of Illumina consumables. This award is not associated with any set-aside program. Illumina has previously provided sequencing systems, reagents, and services to support genomic...
- This is a firm fixed price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Illumina, Inc., a manufacturer of sequencing and array-based genomic analysis solutions. The $3,409.10 contract is for the provision of sequencing systems, reagents, consumables, and related support services to support genomic research and diagnostics. Illumina has a history of prior prime federal contract and...
- This federal contract award to Illumina, Inc. in the amount of $14,112.00 was issued by the National Institute of Allergy and Infectious Diseases (NIAID) within the National Institutes of Health (NIH). The contract is a firm fixed-price purchase order with no set-aside designation. Illumina, a manufacturer of genetic sequencing instruments and reagents, is providing a range of sequencing systems, consumables, and support services under this award to support genomic research and analysis across...
- The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $11,236.05 firm fixed price delivery order contract to Illumina, Inc., a manufacturer of sequencing and array-based solutions for genetic and genomic analysis. The contract is for the delivery of Illumina Sequencing Kits and will be performed in San Diego, California. The award does not have a set-aside designation. Illumina has previously provided...
- This federal contract award was made by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to Illumina, Inc. The $21,164.66 fixed-price contract is for the purchase of Illumina TruSeq sequencing kits. No set-aside provisions were used. Illumina, a manufacturer of sequencing and genomic analysis instruments and reagents, has previously supported genomic research and diagnostics needs across various federal agencies including NIH,...
This federal contract award was made by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to Illumina, Inc., a for-profit manufacturer of genetic sequencing instruments and reagents. The $3,938.22 firm fixed price purchase order is for the delivery of sequencing kits, with a completion date of September 14, 2015. The contract has no set-aside designation. Illumina has a history of providing sequencing systems, reagents, and associated services to federal agencies like the NIH, CDC, USDA, and VA to support genomic research and diagnostics. The company also holds a $3.3 million Indefinite Delivery Contract with the Department of the Navy to supply reagents and controls for their sequencing platforms used to characterize biological threats.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.9k | 9/4/15 |